Home000105 • KRX
add
Yuhan Corp Preference Shares
Nakaraang pagsara
₩88,000.00
Sakop ng araw
₩85,400.00 - ₩88,300.00
Sakop ng taon
₩77,500.00 - ₩117,200.00
Market cap
7.68T KRW
Average na Volume
3.18K
P/E ratio
33.28
Dividend yield
0.69%
Mga balita tungkol sa merkado
Mga Financial
Income Statement
Kita
Net na kita
| (KRW) | Dis 2025info | Y/Y na pagbabago |
|---|---|---|
Kita | 546.07B | 10.07% |
Gastos sa pagpapatakbo | 185.79B | 17.50% |
Net na kita | 114.43B | 1,094.12% |
Net profit margin | 20.96 | 1,003.45% |
Kita sa bawat share | 1.53K | 1,094.81% |
EBITDA | 44.17B | 844.26% |
Aktuwal na % ng binabayarang buwis | 8.91% | — |
Balance Sheet
Kabuuang asset
Kabuuang sagutin
| (KRW) | Dis 2025info | Y/Y na pagbabago |
|---|---|---|
Cash at mga panandaliang investment | 378.08B | 14.33% |
Kabuuang asset | 3.22T | 9.48% |
Kabuuang sagutin | 858.64B | 8.50% |
Kabuuang equity | 2.36T | — |
Natitirang share | 74.76M | — |
Presyo para makapag-book | 2.85 | — |
Return on assets | 2.15% | — |
Return on capital | 2.57% | — |
Cash Flow
Net change in cash
| (KRW) | Dis 2025info | Y/Y na pagbabago |
|---|---|---|
Net na kita | 114.43B | 1,094.12% |
Cash mula sa mga operasyon | 7.70B | -85.62% |
Cash mula sa pag-invest | -11.78B | 38.27% |
Cash mula sa financing | -2.68B | -107.14% |
Net change in cash | -8.29B | -110.81% |
Malayang cash flow | -68.14B | -2,056.14% |
Tungkol
Yuhan Corporation is a South Korean pharmaceutical and chemical company headquartered in Daebang-dong, Dongjak-gu, Seoul. It was established in 1926 by New Il-han and has been listed on the Korea Stock Exchange since 1962. Yuhan is one of the top Korean pharmaceutical companies, along with Celltrion, Samsung Biologics, GC Pharma, and Hanmi Pharmaceutical. Wikipedia
CEO
Itinatag
1926
Website
Mga Empleyado
2,067
